Skip to main content
PolicySpeak
← All files
LCS

LCS

Company · France

not in the EU Transparency RegisterThis organization files on consultations without a register number, so its record here is built from its filings alone. Register facts (staff, costs, accreditations) are not available for it.

2
positions filed
in the 665 files tracked
1
legislative file
of 665 tracked
0
with a full position paper
attached to a submission

Counts here are a floor, never a total: they cover the 665 consultation files tracked so far (57,774 submissions, mostly 2021–26), so an organization's real filing history is larger, not smaller.

Track LCS in PolicySpeak: request access →

Follow LCS

An email when this organization files on a consultation we publish.

We use your email for these updates, and PolicySpeak may contact you about the product. Unsubscribe in one click. Privacy policy.

Work at LCS? so we know who speaks for it.

Their record over time

LCS filed 2 positions between 2 Oct 2025 and 12 Feb 2026, across 1 of the 665 legislative files tracked here.

2025 · 1 filed2026 · 1 filed

What they argued

Simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and support of the European Medicines Agency for the expert panels on medical devices and the list of Union harmonisation legislationfiled 12 Feb 2026source

The proposed measures to simplify the MDR are, in principle, welcome, particularly where they aim to improve efficiency and reduce unnecessary administrative burden. However, their implementation raises significant concerns regarding fairness and competitive balance between manufacturers.

Simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and support of the European Medicines Agency for the expert panels on medical devices and the list of Union harmonisation legislationfiled 2 Oct 2025source

As an SME manufacturing an older medical device, we face significant challenges with the implementation of the MDR. 1. Costs and administrative burden The costs of MDR certification are exorbitant, particularly for SMEs.

Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.

Put LCS next to another organization. Same files, same register facts, side by side. Compare →

Is this your organization?

Everything on this page comes from LCS’s own submissions to the European Commission. We have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.

Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.